COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,436 Articles (22,835 medRxiv, 8,601 bioRxiv)

Most recent first Previous |  Page 673: Articles 6721-6730  | Next

Two mathematical models for the waning of anti-RBD IgG SARS-CoV-2 antibody titers after a two-dose BNT162b2 mRNA vaccination.
Torres, J., Ontanon, J., de Cabo, C., Lozano, J., Requena, M. A., Blas, J., Rodriguez-Garcia, J. L., Mas, A., Cimas, F. J., Solera, J.
10.1101/2022.08.15.22278583 — Posted: 2022-08-26
COVID-19 Contact Tracing Analysis with Bluetooth Technology Using Raspberry Pis
Zhang, D. Y.
10.1101/2022.08.23.504944 — Posted: 2022-08-25
Multisystem Inflammatory Syndrome in Children Managed in the Outpatient Setting: An EHR-based cohort study from the RECOVER program
Jhaveri, R., Webb, R., Razzaghi, H., Schurchard, J., Mejias, A., Bennett, T. D., Jone, P.-N., Thacker, D., Schulert, G. R., Rogerson, C., Cogen, J. D., Bailey, L. C., Forrest, C. B., Lee, G. M., Rao, S.
10.1101/2022.08.25.22279225 — Posted: 2022-08-25
Assessing glucose-6-phosphate dehydrogenase (G6PD) during COVID-19 requires caution: evidence on the impact of the infection upon enzyme activity
Rodrigues, M. G. d. A., Melo, G. C., Dias, A. L. B., Sartim, M. A., Xavier, M. S., Abreu Netto, R. L., Val, F. F. A., Baia-da-Silva, D. C., Brito-Sousa, J. D., Monteiro, W. M., Lacerda, M. V. G., Sampaio, V. S.
10.1101/2022.08.25.22279199 — Posted: 2022-08-25
Modelling SARS-CoV-2 spike-protein mutation effects on ACE2 binding
Thakur, S., Verma, R. K., Kepp, K. P., Mehra, R.
10.1101/2022.08.25.505249 — Posted: 2022-08-25
The diversity of the glycan shield of sarbecoviruses closely related to SARS-CoV-2
Allen, J. D., Ivory, D., Song, G. S., Yong, P., He, T., Andrabi, R., Burton, D., Crispin, M.
10.1101/2022.08.24.505118 — Posted: 2022-08-25
Intentions to get vaccinated against Monkeypox in Healthcare workers in France and Belgium correlates with attitudes toward COVID-19 vaccination
Gagneux-Brunon, A., Dauby, N., LAUNAY, O., Botelho-Nevers, E.
10.1101/2022.08.25.22279205 — Posted: 2022-08-25
Antigen presentation dynamics shape the response to emergent variants like SARS-CoV-2 Omicron strain after multiple vaccinations with wild type strain
Yang, L., Van Beek, M., Wang, Z., Muecksch, F., Canis, M., Hatziioannou, T., Bieniasz, P. D., Nussenzweig, M. C., Chakraborty, A. K.
10.1101/2022.08.24.505127 — Posted: 2022-08-25
Long Covid active case finding: a co-produced community-based pilot within the STIMULATE-ICP study (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways)
Alwan, N. A., Clutterbuck, D., Pantelic, M., Hayer, J., Fisher, L., Hishmeh, L., Heightman, M., Allsopp, G., Wootton, D., Khan, A., Hastie, C., Jackson, M., Rayner, C., Brown, D., Parrett, E., Jones, G., Smith, K., Clarke, R., Mcfarland, S., Gabbay, M., Banerjee, A.
10.1101/2022.08.24.22278954 — Posted: 2022-08-25
Phenotypic evolution of SARS-CoV-2: a statistical inference approach
Benhamou, W., Lion, S., Choquet, R., Gandon, S.
10.1101/2022.08.25.22279206 — Posted: 2022-08-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).